Testing your lungs no longer requires a painful deep breath

The Essentials

• Ciposcillo is a portable oscillometer that identifies asthma and COPD without requiring the patient to blow hard.
• The device is CDSCO approved and uses US FDA cleared technology specifically calibrated for Indian patients.
• It allows children and the elderly to get accurate lung reports by simply breathing naturally into the machine.

The Pulse

Cipla is shifting the focus from treatment to earlier, more accurate detection. Traditional spirometry is a struggle for many because it demands a forced exhale that a five-year-old or an eighty-year-old often cannot manage. Ciposcillo solves this by measuring lung resistance through tidal breathing, the way you breathe while reading this.

The technology isn’t just imported; it includes Z-score interpretations based on Indian reference values. This is crucial because lung capacity varies across ethnicities, and a one-size-fits-all global standard often leads to misdiagnosis in India. By using local benchmarks, the device ensures the results are relevant to the person sitting in the chair.

Is the Ciposcillo available for home use? No, this is a clinical-grade tool designed for doctors and diagnostic centres to improve the accuracy of lung function tests across India. It was launched on 6 May 2026 and is currently being rolled out to healthcare providers across the country.

The Snapshot

The Big Picture

India carries a massive burden of respiratory illness, yet diagnostic tools like the traditional spirometer often go unused because they are difficult to operate or require perfect patient cooperation. By introducing an effort-independent tool, Cipla is competing with established diagnostic brands like Vyaire. The shift towards portable, point-of-care diagnostics in India suggests a future where your local GP can provide a specialist-level lung report in minutes rather than referring you to a major city hospital.

The India Prospective

Respiratory health is a growing concern in cities like Delhi and Mumbai due to air quality. While Ciposcillo is primarily for clinical use, its arrival at local diagnostic centres means you can finally get your parents or children tested without the frustration of repeated, failed forced breath attempts. Since it is designed for Indian clinical practice, it fits directly into existing medical workflows and hospital environments across the country.

The Inside Intel

The device uses Z-scores, which are essentially a way of comparing your results to a normal person of your same age, height, and ethnicity. Most devices in India still use Western data sets, but Ciposcillo is one of the few that recognises the specific physiological benchmarks of the Indian population.

The UDHQ. Take

Unbox Daily HQ. finds this to be a significant leap for family health management. If you have an elderly parent with a persistent cough or a child with suspected asthma, ask your doctor if they use an oscillometer like Ciposcillo instead of a standard spirometer. The lack of physical strain makes the diagnostic process far less intimidating and much more accurate for those who cannot follow complex breathing instructions. It is a necessary upgrade for Indian clinics dealing with rising pollution-related ailments.

Best for: Caregivers of elderly parents who need a stress-free way to monitor lung health.

Who Is This For: Perfect for 30 to 65 year olds managing the health of their children or parents in urban India.

The Checkout

Cipla – India Page

The Source

Cipla Limited